Oral valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic stem cell transplantation recipients

被引:0
|
作者
Pastore, D. [1 ]
Carluccio, P. [1 ]
Gaudio, F. [1 ]
Perrone, T. [1 ]
Delia, M. [1 ]
Albano, F. [1 ]
Manduzio, P. [1 ]
Fesce, V. [1 ]
Mongelli, P. [1 ]
Liso, V. [1 ]
Specchia, G. [1 ]
机构
[1] Univ Bari, Bari, Italy
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S266 / S267
页数:2
相关论文
共 50 条
  • [31] Clinical and economic burden of pre-emptive therapy of cytomegalovirus infection in hospitalized allogeneic hematopoietic cell transplant recipients
    El Haddad, Lynn
    Ghantoji, Shashank S.
    Park, Anne K.
    Batista, Marjorie V.
    Schelfhout, Jonathan
    Hachem, Jack
    Lobo, Yadira
    Jiang, Ying
    Rondon, Gabriela
    Champlin, Richard
    Chemaly, Roy F.
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (01) : 86 - 95
  • [32] Pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation guided by quantitative real time-PCR
    Banan, A.
    Ramzi, M.
    Varnik, E.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S335 - S335
  • [33] Pre-emptive therapy for cytomegalovirus infection after allogeneic stem cell transplantation guided by quantitative real time-PCR
    de la Cruz Vicente, F.
    Gracia-Ahufinger, I.
    Perez-Romero, P.
    Aguilar Guisado, M.
    Parody Ruiz-Berdejo, R.
    Cisneros Herreros, J. M.
    Urbano-Ispizua, A.
    Espigado, I.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S229 - S229
  • [34] Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Katsuto Takenaka
    Tetsuya Eto
    Koji Nagafuji
    Kenjiro Kamezaki
    Yayoi Matsuo
    Goichi Yoshimoto
    Naoki Harada
    Maki Yoshida
    Hideho Henzan
    Ken Takase
    Toshihiro Miyamoto
    Koichi Akashi
    Mine Harada
    Takanori Teshima
    International Journal of Hematology, 2009, 89 : 231 - 237
  • [35] Treatment of cytomegalovirus infection with oral valganciclovir in allogeneic haematopoietic stem cell transplantation
    Uresandi, A
    Bermudez, A
    Yañez, L
    Gonzalez-Mesones, B
    Puente, M
    Baro, J
    Conde, E
    Iriondo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S187 - S187
  • [36] Oral valganciclovir as preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Takenaka, Katsuto
    Eto, Tetsuya
    Nagafuji, Koji
    Kamezaki, Kenjiro
    Matsuo, Yayoi
    Yoshimoto, Goichi
    Harada, Naoki
    Yoshida, Maki
    Henzan, Hideho
    Takase, Ken
    Miyamoto, Toshihiro
    Akashi, Koichi
    Harada, Mine
    Teshima, Takanori
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (02) : 231 - 237
  • [37] Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients
    Gerna, Giuseppe
    Lilleri, Daniele
    Zecca, Marco
    Alessandrino, Emilio Paolo
    Baldanti, Fausto
    Revello, Maria Grazia
    Locatelli, Franco
    HAEMATOLOGICA, 2005, 90 (04) : 526 - 533
  • [38] Valganciclovir is safe and effective as pre-emptive treatment for CMV reactivation in allogeneic hematopoietic stem cell transplantation
    Pastano, R.
    Gigli, F.
    Andreola, G.
    Peccatori, F. A.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 468 - 468
  • [39] Valganciclovir for pre-emptive therapy of cytomegalovirus viraemia after hematopoietic stem cell transplantation: a prospective multi-center trial
    Liu Kai-yan
    Wang Yu
    Han Ming-zhe
    Huang He
    Chen Hu
    Liu Qi-fa
    Wang Jian-min
    Liu Ting
    Song Yong-ping
    Ma Jun
    Wu De-pei
    Zou Ping
    Huang Xiao-jun
    CHINESE MEDICAL JOURNAL, 2010, 123 (16) : 2199 - 2205